in a randomized , double-blind comparative study involving a total of 1630 outpatients , tenoxicam , a new nonsteroidal anti-inflammatory drug belonging to the oxicam group , piroxicam and diclofenac retard were tested for their efficacy und tolerability in the treatment of osteoarthritis and extra-articular rheumatism .
C0031990
piroxicam
C0029408
osteoarthritis